[Emergent mycoses].
Naito
Yasushi
Y
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D017809:Fatal Outcome; D015725:Fluconazole / Q000627:therapeutic use; D005936:Glucans / Q000097:blood; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D010038:Otorhinolaryngologic Diseases / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D012307:Risk Factors; D047071:beta-Glucans
D000935:Antifungal Agents; D015415:Biomarkers; D005936:Glucans; D047071:beta-Glucans; D000666:Amphotericin B; D015725:Fluconazole; C033363:beta-1,3-glucan